Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 12.85B | 9.86% |
| Income (loss) before taxes | profit | 4.01B | 34.11% |
| Total expenses | cost | 8.83B | 1.52% |
| Net income (loss) | profit | 3.62B | 22.20% |
| Income tax expense (benefit) | cost | 396.33M | 1114.70% |
| Net claims and claim expenses incurred | cost | 5.62B | 5.30% |
| Acquisition expenses | cost | 2.55B | -3.52% |
| Operational expenses | cost | 464.48M | -6.47% |
| Interest expense (note 9) | cost | 120.85M | 28.88% |
| Corporate expenses | cost | 82.01M | -39.16% |
| Net income (loss) | profit | 2.68B | 43.41% |
| Net income (loss) attributable to redeemable noncontrolling interest | cost | 935.41M | -14.20% |
| Net income (loss) available (attributable) to renaissancere common shareholders | profit | 2.65B | 44.25% |
| Dividends on preference shares | cost | 35.38M | 0.00% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Fixed maturity investments trading | assets | 24.88B | 5.61% |
| Short term investments, at fair value - amortized cost $4,760,027 at december 31, 2025 (2024 - $4,532,166) (notes 5 and 6) | assets | 4.76B | 5.03% |
| Other investments | assets | 4.57B | 5.77% |
| Total equity investments | assets | 1.73B | 1371.68% |
| Investments in other ventures, under equity method (note 5) | assets | 121.87M | 18.59% |
| Investments | assets | 36.07B | 10.52% |
| Premiums receivable (note 7) | assets | 7.25B | -0.52% |
| Reinsurance recoverable | assets | 3.90B | -12.98% |
| Cash and cash equivalents | assets | 1.73B | 3.26% |
| Deferred acquisition costs and value of business acquired | assets | 1.54B | -0.89% |
| Prepaid reinsurance premiums | assets | 993.78M | 11.87% |
| Deferred tax asset | assets | 701.93M | 0.12% |
| Goodwill and other intangible assets | assets | 633.09M | -10.09% |
| Receivable for investments sold | assets | 414.52M | 352.20% |
| Other assets | assets | 328.09M | -26.11% |
| Accrued investment income | assets | 233.69M | -1.93% |
| Assets | assets | 53.80B | 6.10% |
| Liabilities | liabilities | 34.59B | 4.32% |
| Redeemable noncontrolling interests | liabilities | 7.60B | 8.95% |
| Total shareholders’ equity attributable to renaissancere | equity | 11.61B | 9.78% |
| Accumulated other comprehensive income (loss) | equity | 12.63M | -14.43% |
| Reserve for claims and claim expenses | liabilities | 22.30B | 4.69% |
| Unearned premiums | liabilities | 6.03B | 1.31% |
| Reinsurance balances payable | liabilities | 2.54B | -9.41% |
| Debt | liabilities | 2.33B | 23.45% |
| Other liabilities | liabilities | 856.30M | -19.23% |
| Payable for investments purchased | liabilities | 533.10M | 253.70% |
| Aggregate | equity | 11.62B | 9.75% |
| Retained earnings (note 12) | equity | 10.83B | 30.83% |
| Preference shares: $1.00 par value - 30,000 shares issued and outstanding at december 31, 2025 (2024 - 30,000) | equity | 750.00M | 0.00% |
| Common shares: $1.00 par value - 43,961,539 shares issued and outstanding at december 31, 2025 (2024 - 50,180,987) | equity | 43.96M | -12.39% |
| Item | Value |
|---|---|
| Net income (loss) | 3.62B |
| Reserve for claims and claim expenses | 998.85M |
| Increase (decrease) in reinsurance recoverable | 581.48M |
| Unearned premiums | 77.76M |
| Increase (decrease) in premiums receivable | 37.77M |
| Increase (decrease) in deferred policy acquisition costs | 13.82M |
| Depreciation, amortization and accretion, net | -14.12M |
| Income (loss) from equity method investments, net of dividends or distributions | -17.22M |
| Increase (decrease) in other operating assets and liabilities, net | -51.73M |
| Increase (decrease) in prepaid reinsurance premiums | -105.45M |
| Increase (decrease) in reinsurance payables | -263.83M |
| Gain (loss) on investments | -1.18B |
| Item | Value |
|---|---|
| Proceeds from sales of short term investments | 45.56B |
| Proceeds from sales and maturities of fixed maturity investments trading | 12.69B |
| Proceeds from sales of other investments | 1.01B |
| Payments for (proceeds from) derivative instrument, investing activities | 564.34M |
| Proceeds from sales of equity investments | 1.60M |
| Return of investments in other ventures | 321000 |
| Payments to acquire equity method investments | -1.09M |
| Payments to acquire other investments | -1.48B |
| Payments to acquire trading securities, short-term | -1.56B |
| Payment for acquisition, trading security, held-for-investment | -13.30B |
| Payments to acquire short-term investments | -45.69B |
| Item | Value |
|---|---|
| Issuance of debt, net of expenses | 889.11M |
| Subscriptions of third-party redeemable noncontrolling interest shares | 212.24M |
| Drawdown of medici revolving credit facility | 75.00M |
| Payment, tax withholding, share-based payment arrangement | -23.52M |
| Payments of ordinary dividends, preferred stock and preference stock | -35.38M |
| Payments of ordinary dividends, common stock | -74.84M |
| Repayments of lines of credit | -75.00M |
| Payments for repurchase of redeemable noncontrolling interest | -328.44M |
| Repayments of debt | -450.00M |
| Payments for repurchase of common stock | -1.60B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 1.68B |
| Cash and cash equivalents, end of period | 1.73B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support